Rapid communication Open Access
Like 0


The Rhône-Loire metropolitan areas’ 2020/21 respiratory syncytial virus (RSV) epidemic was delayed following the implementation of non-pharmaceutical interventions (NPI), compared with previous seasons. Very severe lower respiratory tract infection incidence among infants ≤ 3 months decreased twofold, the proportion of cases among children aged > 3 months to 5 years increased, and cases among adults > 65 years were markedly reduced. NPI appeared to reduce the RSV burden among at-risk groups, and should be promoted to minimise impact of future RSV outbreaks.


Article metrics loading...

Loading full text...

Full text loading...



  1. Cowling BJ, Ali ST, Ng TWY, Tsang TK, Li JCM, Fong MW, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020;5(5):e279-88.  https://doi.org/10.1016/S2468-2667(20)30090-6  PMID: 32311320 
  2. Foley DA, Yeoh DK, Minney-Smith CA, Martin AC, Mace AO, Sikazwe CT, et al. The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019-Related Public Health Measures. Clin Infect Dis. 2021;ciaa1906. http://dx.doi.org/ https://doi.org/10.1093/cid/ciaa1906 PMID:33594407
  3. National Institute for Communicable Diseases (NICD). Weekly Respiratory Pathogens Surveillance Report 2021. Johannesburg: NICD; 2021. Available from: https://www.nicd.ac.za/diseases-a-z-index/covid-19/surveillance-reports/weekly-respiratory-pathogens-surveillance-report-week/
  4. Casalegno JS, Javouhey E, Ploin D, Valette M, Fanget R, Couray-Targe S, et al. Delayed Start of the Respiratory Syncytial Virus Epidemic at the End of the 20/21 Northern Hemisphere Winter Season, Lyon, France. MedRxiv 2021.03.12.21253446. 2021. Available from: https://www.medrxiv.org/content/10.1101/2021.03.12.21253446v1
  5. Delestrain C, Danis K, Hau I, Billard MN, Kragten L, Cohen R, et al. Impact of COVID-19 social distancing on viral infection in France: a delayed outbreak of RSV. Authorea. 2021 Available from: https://www.authorea.com/users/333160/articles/517042-impact-of-covid-19-social-distancing-on-viral-infection-in-france-a-delayed-outbreak-of-rsv?commit=fae8a5d45e0c95e91e62791556ee8db46a422b34
  6. Sciensano. Weekly bulletin respiratory infections, Season 2020-2021. Brussels: Sciensano; 2021. Available from: https://epidemio.wiv-isp.be/ID/diseases/SiteAssets/Pages/Influenza/WeeklyBulletinRespiratoryInfections.pdf
  7. Gaymard A, Bouscambert-Duchamp M, Pichon M, Frobert E, Vallee J, Lina B, et al. Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014. J Clin Virol. 2018;102:12-8.  https://doi.org/10.1016/j.jcv.2018.02.004  PMID: 29471266 
  8. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266-75.  https://doi.org/10.1016/j.jinf.2020.05.046  PMID: 32473235 
  9. Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS; WHO RSV Vaccine Consultation Expert Group. WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015. Vaccine. 2016;34(2):190-7. http://dx.doi.org/ https://doi.org/10.1016/j.vaccine.2015.05.093 PMID:26100926
  10. Kramer R, Duclos A, Lina B, Casalegno JS, VRS study group in Lyon. Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France. Vaccine. 2018;36(45):6591-3.  https://doi.org/10.1016/j.vaccine.2018.09.029  PMID: 30266485 
  11. Santé publique France. Bulletin épidémiologique bronchiolite, Saison 2020-2021. Saint-Maurice : Santé publique France, 2021. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/bronchiolite/donnees/#tabs
  12. Trenholme A, Webb R, Lawrence S, Arrol S, Taylor S, Ameratunga S, et al. COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020. Emerg Infect Dis. 2021;27(2):641-3.  https://doi.org/10.3201/eid2702.204041  PMID: 33263515 
  13. Hall CB, Simőes EA, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol. 2013;372:39-57.  https://doi.org/10.1007/978-3-642-38919-1_2  PMID: 24362683 
  14. Li Y, Johnson EK, Shi T, Campbell H, Chaves SS, Commaille-Chapus C, et al. National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study. Lancet Respir Med. 2021;9(2):175-85.  https://doi.org/10.1016/S2213-2600(20)30322-2  PMID: 32971018 
  15. Baker RE, Mahmud AS, Wagner CE, Yang W, Pitzer VE, Viboud C, et al. Epidemic dynamics of respiratory syncytial virus in current and future climates. Nat Commun. 2019;10(1):5512.  https://doi.org/10.1038/s41467-019-13562-y  PMID: 31797866 
  16. Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci USA. 2020;117(48):30547-53.  https://doi.org/10.1073/pnas.2013182117  PMID: 33168723 

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error